DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Usefulness of Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux.

Information source: Nantes University Hospital
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Recurrence of Urinary Tract Infection

Intervention: Antimicrobial prophylaxis (Procedure)

Phase: N/A

Status: Active, not recruiting

Sponsored by: Nantes University Hospital

Official(s) and/or principal investigator(s):
Claude GUYOT, MD, Principal Investigator, Affiliation: Nantes University Hospital

Summary

Randomised, prospective, multicentric study in order to assess the usefulness of antimicrobial prophylaxis in children with isolated vesico-ureteral reflux (grade III or less).

Clinical Details

Official title: Antimicrobial Prophylaxis in Children With Isolated Vesico-Ureteral Reflux. A Randomised Prospective Study of Continuous Low Dose of Trimethoprim-Sulfamethoxazole Versus Surveillance.

Study design: Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment

Primary outcome: End point : recurrence of urinary tract infection during the study period (0 รจ 18 months)

Secondary outcome:

1) Type of urinary tract infection (pyelonephritis or cystitis)

2) Evaluation of the quality of life with a validated questionnaire done at 9 months

Detailed description: A voidingcystourethrogram was performed for each child less than 3 year old with a first urinary tract infection. In case of vesico-ureteral reflux, a randomisation was done between continuous antimicrobial prophylaxis with low dose of trimethoprim-sulfamethoxazole and no antibioprophylaxis. Duration of follow up was 18 months

Eligibility

Minimum age: N/A. Maximum age: 3 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Children less than 3 year old

- First proved urinary tract infectionIsolated vesico-ureteral reflux

- Parents have been fully informed and have given written informed consent to

participate in the study

Exclusion Criteria:

-

Locations and Contacts

Nantes University Hospital, Nantes, France
Additional Information

Starting date: April 2001
Last updated: September 12, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009